The key is advanced negotiations and with more than one which should result in a better deal and with wider faster reach.
New interest has come from potential tier 1 partners not there previously and probably stems from big pharma showing interest and supports the uptake of test.
Ann: PromarkerD US market update, page-11
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
86.0¢ |
Change
-0.010(1.15%) |
Mkt cap ! $110.0M | |||
| Open | High | Low | Value | Volume |
| 86.0¢ | 86.0¢ | 83.0¢ | $95.14K | 112.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10011 | 83.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 86.0¢ | 4016 | 1 |
View Market Depth
| Last trade - 14.51pm 28/08/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |